🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
32.10
+2.31 (7.75%)
Nov 19, 2026, 1:58 PM EST - Market open

UroGen Pharma Revenue

UroGen Pharma had revenue of $89.00M in the quarter ending September 30, 2026, with 223.85% growth. This brings the company's total for the last twelve months to $250.25M, up 159.29% year-over-year. In the year 2025, UroGen Pharma had annual revenue of $109.79M with 21.45% growth. That makes UroGen Pharma the 15,861st largest company in the world by revenue and 2,728th in the United States.

Revenue (ttm)
$250.25M
Revenue Growth
+159.29%
P/S Ratio
5.84
Revenue / Employee
$834,177
Employees
300
Market Cap
1.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025109.79M19.39M21.45%
Dec 31, 202490.40M7.69M9.29%
Dec 31, 202382.71M18.36M28.52%
Dec 31, 202264.36M16.32M33.96%
Dec 31, 202148.04M36.24M307.17%
Dec 31, 202011.80M11.78M65,450.00%
Dec 31, 201918.00K-1.11M-98.40%
Dec 31, 20181.13M-7.03M-86.17%
Dec 31, 20178.16M-9.37M-53.46%
Dec 31, 201617.53M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Nurix Therapeutics701.94M
Immunocore Holdings429.30M
Nuvation Bio201.73M
Precigen156.94M
uniQure20.17M
ADARx Pharmaceuticals6.13M
Revenue Rankings